Clinical trials using chemopreventive vitamin D analogs in breast cancer

Cancer Journal

Volumn 12, Issue 6, 2006, Pages 445-450

  Vijayakumar, Srinivasan ^a,e   Boerner, Philip S ^a   Mehta, Rajeshwari R ^b   Packianathan, S ^c   Mehta, Rajendra G ^d   Das Gupta, Tapas K ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^c MAYO CLINIC   (United States)

^d ITT Research Institute   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Breast cancer; Chemoprevention; Vitamin D

Indexed keywords

CALCIPOTRIOL; CALCIUM; COLECALCIFEROL; SEOCALCITOL; UNCLASSIFIED DRUG; VITAMIN D DERIVATIVE; VITAMIN D RECEPTOR; VITAMIN D5;

ANTINEOPLASTIC ACTIVITY; BREAST CANCER; CANCER RISK; CANCER THERAPY; CHEMOPROPHYLAXIS; CLINICAL TRIAL; HUMAN; HYPERCALCEMIA; PRIORITY JOURNAL; REVIEW; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION;

BREAST NEOPLASMS; CLINICAL TRIALS; FEMALE; HUMANS; VITAMIN D;

EID: 33845897097     PISSN: 15289117     EISSN: 1540336X     Source Type: Journal    
DOI: 10.1097/00130404-200611000-00001     Document Type: Review

References (45)

1. Coyle YM. The effect of environment on breast cancer risk. Breast Cancer Res Treat 2004 Apr;84(3):273-288.
2. Blot WJ, Fraumeni JF Jr, Stone BJ. Geographic patterns of breast cancer in the United States. J Natl Cancer Inst 1977 Nov;59(5):1407-1411.
3. Jemal A, Murray T, Ward E, et al. Cancer statistics, 2005. CA Cancer J Clin 2005 Jan-Feb;55(1):10-30.
4. Hong WK, Sporn MB. Recent advances in chemoprevention of cancer. Science 1997 Nov 7;278(5340):1073-1077.
5. Wattenberg LW. Inhibition of tumorigenesis in animals, in: Principles of Chemoprevention IARC Handbook on Chemoprevention, IARC Scientific Publications, International Agency for Research on Cancer: Lyon, France, 1996:151-158.
6. Packianathan S, Mehta RG, Mehta RR, et al. Designing a randomized phase I/II prostate cancer chemoprevention trial using 1alpha-hydroxy-24-ethyl- cholecalciferol, an analogue of vitamin D3. Cancer J 2004 Nov-Dec;10(6):357-367.
7. Lips P. Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. Endocr Rev 2001 Aug; 22(4):477-501.
8. Welsh J, Wietzke JA, Zinser GM, et al. Vitamin D-3 receptor as a target for breast cancer prevention. J Nutr 2003 Jul; 133[suppl 7]:2425S-2433S.
9. Guy M, Lowe LC, Bretherton-Watt D, et al. Vitamin D receptor gene polymorphisms and breast cancer risk. Clin Cancer Res 2004 Aug 15;10(16):5472-5481.
10. Doll R. The lessons of life: keynote address to the nutrition and cancer conference. Cancer Res 1992 Apr 1;52[suppl 7]:2024s-2029s.
11. Mellanby E. An experimental investigation on rickets. Lancet I 1919:407-412.
12. McCollum EV, Simmonds N, Becker JE, et al. Studies on experimental rickets. XXI. An experimental demonstration of the existence of a vitamin which promotes calcium deposition. J Biol Chem 1922;53(3):293.
13. Bortman P, Folgueira MA, Katayama ML, et al. Antiproliferative effects of 1,25-dihydroxyvitamin D3 on breast cells: a mini review. Braz J Med Biol Res 2002;35(1):1-9.
14. Shen Q, Brown PH. Novel agents for the prevention of breast cancer: targeting transcription factors and signal transduction pathways. J Mammary Gland Biol Neoplasia 2003 Jan;8(1):45-73.
15. Bertone-Johnson ER, Chen WY, Holick MF, et al. Plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D and risk of breast cancer. Cancer Epidemiol Biomarkers Prev 2005 Aug; 14(8):1991-1997.
16. Garland CF, Comstock GW, Garland FC, et al. Serum 25-hydroxyvitamin D and colon cancer: eight-year prospective study. Lancet 1989 Nov 18;2(8673):1176-1178.
17. Gorham ED, Garland CF, Garland FC. Acid haze air pollution and breast and colon cancer mortality in 20 Canadian cities. Can J Public Health 1989 Mar-Apr;80(2):96-100.
18. Schwartz GG, Hulka BS. Is vitamin D deficiency a risk factor for prostate cancer? (Hypothesis). Anticancer Res 1990 Sep-Oct;10(5A):1307-1311.
19. Garland FC, Garland CF, Gorham ED, et al. Geographic variation in breast cancer mortality in the United States: a hypothesis involving exposure to solar radiation. Prev Med 1990 Nov; 19(6):614-22.
20. Hanchette CL, Schwartz GG. Geographic patterns of prostate cancer mortality. Evidence for a protective effect of ultraviolet radiation. Cancer 1992 Dec 15;70(12):2861-2869.
21. Peller S. Carcinogenesis as a means of reducing cancer mortality. Lancet 1936;2:552-556.
22. Apperly FL. The relation of solar radiation to cancer mortality in North America. Cancer Res 1941;1:191-195.
23. Sturgeon SR, Schairer C, Grauman D, et al. Trends in breast cancer mortality rates by region of the United States, 1950-1999. Cancer Causes Control 2004 Dec;15(10):987-995.
24. John EM, Schwartz GG, Dreon DM, et al. Vitamin D and breast cancer risk: the NHANES I Epidemiologic follow-up study, 1971-1975 to 1992. National Health and Nutrition Examination Survey. Cancer Epidemiol Biomarkers Prev 1999 May; 8(5):399-406.
25. Janowsky EC, Lester GE, Weinberg CR, et al. Association between low levels of 1,25-dihydroxyvitamin D and breast cancer risk. Public Health Nutr 1999 Sep;2(3):283-291.
26. Gorham ED, Garland FC, Garland CF. Sunlight and breast cancer incidence in the USSR. Int J Epidemiol 1990 Dec;19(4): 820-824.
27. Freedman DM, Dosemeci M, McGlynn K. Sunlight and mortality from breast, ovarian, colon, prostate, and non-melanoma skin cancer: a composite death certificate based case-control study. Occup Environ Med 2002 Apr;59(4):257-262.
28. Grant WB. An ecologic study of dietary and solar ultraviolet-B links to breast carcinoma mortality rates. Cancer 2002 Jan 1;94(1):272-281.
29. Shin MH, Holmes MD, Hankinson SE, et al. Intake of dairy products, calcium, and vitamin D and risk of breast cancer. J Natl Cancer Inst 2002 Sep 4;94(17):1301-1311.
30. Knekt P, Jarvinen R, Seppanen R, et al. Intake of dairy products and the risk of breast cancer. Br J Cancer 1996 Mar;73(5):687-691.
31. Mawer EB, Walls J, Howell A, et al. Serum 1,25-dihydroxyvitamin D may be related inversely to disease activity in breast cancer patients with bone metastases. J Clin Endocrinol Metab 1997 Jan;82(1):118-122.
32. Hiatt RA, Krieger N, Lobaugh B, et al. Prediagnostic serum vitamin D and breast cancer. J Natl Cancer Inst 1998 Mar 18; 90(6):461-463.
33. Simard A, Vobecky J, Vobecky JS. Vitamin D deficiency and cancer of the breast: an unprovocative ecological hypothesis. Can J Public Health 1991 Sep-Oct;82(5):300-303.
34. Laden F, Spiegelman D, Neas LM, et al. Geographic variation in breast cancer incidence rates in a cohort of U.S. women. J Natl Cancer Inst 1997 Sep 17;89(18):1373-1378.
35. Robsahm TE, Tretli S, Dahlback A, et al. Vitamin D3 from sunlight may improve the prognosis of breast-, colon- and prostate cancer (Norway). Cancer Causes Control 2004 Mar;15(2): 149-158.
36. Vijayakumar S, Mehta RR, Boerner PS, et al. Clinical trials involving vitamin D analogs in prostate cancer. Cancer J 2005 Sep-Oct;11(5):362-373.
37. Bower M, Colston KW, Stein RC, et al. Topical calcipotriol treatment in advanced breast cancer. Lancet 1991 Mar 23; 337(8743):701-702.
38. Hansen CM, Hamberg KJ, Binderup E, et al. Seocalcitol (EB 1089): a vitamin D analogue of anti-cancer potential. Background, design, synthesis, pre-clinical and clinical evaluation. Curr Pharm Des 2000 May;6(7):803-828.
39. The Women's Health Initiative Study Group. Design of the Women's Health Initiative clinical trial and observational study. The Women's Health Initiative Study Group. Control Clin Trials 1998 Feb;19(1):61-109.
40. Wactawski-Wende J, Kotchen JM, Anderson GL, et al. Calcium plus vitamin D supplementation and the risk of colorectal cancer. N Engl J Med 2006;354:684-696.
41. Welsh J. Vitamin D and breast cancer: insights from animal models. Am J Clin Nutr 2004 Dec;80[suppl 7]:1721S-1724S.
42. Mehta RG, Mehta RR. Vitamin D and cancer. J Nutr Biochem 2002 May;13(5):252-264.
43. Welsh J, Wietzke JA, Zinser GM, et al. Impact of the Vitamin D3 receptor on growth-regulatory pathways in mammary gland and breast cancer. J Steroid Biochem Mol Biol 2002 Dec; 83(1-5):85-92.
44. Lowe L, Hansen CM, Senaratne S, et al. Mechanisms implicated in the growth regulatory effects of vitamin D compounds in breast cancer cells. Recent Results Cancer Res 2003;164:99-110.
45. Gulliford T, English J, Colston KW, et al. A phase I study of the vitamin D analogue EB 1089 in patients with advanced breast and colorectal cancer. Br J Cancer 1998 Jul;78(1):6-13.